Coeliac disease is a common chronic inflammatory enteropathy characterized by villous atrophy and crypt hyperplasia in the small intestine. The mechanism of the intestinal damage in coeliac disease remains unclear. Glucagon-like peptide (GLP)-2 is an enterotrophic peptide that causes crypt hyperplasia and intestinal cell proliferation. We postulate that GLP-2 may be involved in the mucosal changes found in coeliac disease.
|Number of pages||8|
|Journal||EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY|
|Publication status||Published - Feb 2006|
ASJC Scopus subject areas